Skip to main content
. 2025 Sep 5;13(9):952. doi: 10.3390/vaccines13090952
BCA Bicinchoninic Acid Assay
CDAP 1-cyano-4-dimethylaminopyridinium tetrafluoroborate
CPS Capsular polysaccharide
EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide)
EOD Early Onset Disease
GBS Group B Streptococcus
GMC(s) Geometric Mean concentration(s)
HZ-PEG-HZ Hydrazide-Polyethylene Glycol-Hydrazide
IAP Intrapartum Antibiotic Prophylaxis
IgG Immunoglobulin G
LOD Late Onset Disease
LMICs Low- and Middle-Income Countries
MBIA Multiplexed Bead-based Immunoassay
MNT Maternal and Neonatal Tetanus
NZW New Zealand White
OPA Opsonophagocytic Killing Assay
PS Polysaccharide
rCRM197 recombinant Cross-Reacting Material197
SEC-MALLS Size Exclusion Chromatography Multi Angle Laser Light Scattering
ST Serotype
SToRR Serological Thresholds of Risk Reduction
TMP Trans Membrane Pressure
TNBS 2,4,6-trinitrobenzene sulfonic acid